Literature DB >> 10353870

Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.

Y Kurono1, M Yamamoto, K Fujihashi, S Kodama, M Suzuki, G Mogi, J R McGhee, H Kiyono.   

Abstract

To determine the efficacy of a mucosal vaccine against nontypeable Haemophilus influenzae (NTHi), mice were immunized nasally, orally, intratracheally, or intraperitoneally with NTHi antigen together with cholera toxin. Antigen-specific IgA antibody titers in nasal washes and the numbers of antigen-specific IgA-producing cells in nasal passages showed the greatest increases in mice immunized nasally. Cytokine analysis showed that interferon-gamma, interleukin (IL)-2, IL-5, IL-6, and IL-10 were induced by nasal immunization, suggesting that Th2- and Th1-type cells were generated. Furthermore, bacterial clearance of a homologous strain of NTHi from the nasal tract was significantly enhanced in the nasal immunization group. These findings suggest that nasal immunization is an effective vaccination regimen for the induction of antigen-specific mucosal immune responses, which reduce the colonization of NTHi in the nasal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353870     DOI: 10.1086/314827

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

2.  In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Authors:  Donata Medaglini; Annalisa Ciabattini; Anna Maria Cuppone; Caterina Costa; Susanna Ricci; Massimo Costalonga; Gianni Pozzi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.

Authors:  A Sabirov; S Kodama; T Hirano; M Suzuki; G Mogi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Vaginal memory T cells induced by intranasal vaccination are critical for protective T cell recruitment and prevention of genital HSV-2 disease.

Authors:  Ayuko Sato; Aldina Suwanto; Manami Okabe; Shintaro Sato; Tomonori Nochi; Takahiko Imai; Naoto Koyanagi; Jun Kunisawa; Yasushi Kawaguchi; Hiroshi Kiyono
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

5.  Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae.

Authors:  K L Ostberg; M W Russell; T F Murphy
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

6.  Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

7.  Probing local innate immune responses after mucosal immunisation.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immune Based Ther Vaccines       Date:  2010-09-13

Review 8.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

9.  A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.

Authors:  Tatsuya Fukuiwa; Shinichi Sekine; Ryoki Kobayashi; Hideaki Suzuki; Kosuke Kataoka; Rebekah S Gilbert; Yuichi Kurono; Prosper N Boyaka; Arthur M Krieg; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Vaccine       Date:  2008-07-14       Impact factor: 3.641

10.  Nasal-associated lymphoid tissue (NALT): frequency and localization in young children.

Authors:  A S Debertin; T Tschernig; H Tönjes; W J Kleemann; H D Tröger; R Pabst
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.